10:52 AM EST - Helix BioPharma Corp. : Has entered into a non-binding term sheet to divest the remaining shares it holds in its Polish subsidiary, Helix Immuno-Oncology S.A., representing approximately 51% of the issued and outstanding shares of HIO prior to the HIO Private Placement. Helix BioPharma Corp.
shares T.HBP are trading unchanged at $0.80.
